Development and reversibility of impaired mineralization associated with lanthanum carbonate treatment in chronic renal failure rats

Bone

Volumn 38, Issue 6, 2006, Pages 803-810

  Bervoets, An R J ^a   Oste, Line ^a   Behets, Geert J ^a   Dams, Geert ^a   Blust, Ronny ^a   Marynissen, Rita ^a   Geryl, Hilde ^a   De Broe, Marc E ^a   D'Haese, Patrick C ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Hyperphosphatemia; Lanthanum; Mineralization defect; Phosphate depletion; Renal osteodystrophy

Indexed keywords

CALCIUM; CREATININE; LANTHANUM CARBONATE; PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BONE DENSITY; BONE DISEASE; BONE MINERALIZATION; CALCIUM BLOOD LEVEL; CALCIUM BONE LEVEL; CALCIUM URINE LEVEL; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG TISSUE LEVEL; DRUG URINE LEVEL; HISTOLOGY; MALE; MORPHOMETRICS; NONHUMAN; PHOSPHATE BLOOD LEVEL; RAT;

ANIMALS; BONE AND BONES; BONE DENSITY; CALCIFICATION, PHYSIOLOGIC; CALCIUM; KIDNEY FAILURE, CHRONIC; LANTHANUM; MALE; PHOSPHATES; RATS; RATS, WISTAR;

EID: 33749371216     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2005.11.022     Document Type: Article

References (25)

1. Chertow G.M., Burke S.K., Lazarus J.M., Stenzel K.H., Wombolt D., Goldberg D., et al. Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure. Am. J. Kidney Dis. 29 (1997) 66-71
2. Damment S.J.P., and Shen V. Assessment of effects of lanthanum carbonate with and without phosphate supplementation on bone mineralization in uremic rats. Clin. Nephrol. 63 (2005) 127-137
3. D'Haese P.C., Spasovski G.B., Sikole A., Hutchison A., Freemont T.J., Sulkova S., et al. A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients. Kidney Int., Suppl. (2003) S73-S78
4. Joy M.S., and Finn W.F. Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia. Am. J. Kidney Dis. 42 (2003) 96-107
5. Oste L., Bervoets A.R., Behets G., Dams G., Marijnissen R.L., Geryl H., et al. Time-evolution and reversibility of strontium-induced osteomalacia in chronic renal failure rats. Kidney Int. 67 (2005) 920-930
6. Sontag W. Multicompartment kinetic models for the metabolism of americium, plutonium and uranium in rats. Hum. Toxicol. 5 (1986) 163-173
7. Li W.P., Ma D.S., Higginbotham C., Hoffman T., Ketring A.R., Cutler C.S., et al. Development of an in vitro model for assessing the in vivo stability of lanthanide chelates. Nucl. Med. Biol. 28 (2001) 145-154
8. Freemont T., and Malluche H.H. Utilization of bone histomorphometry in renal osteodystrophy: demonstration of a new approach using data from a prospective study of lanthanum carbonate. Clin. Nephrol. 63 (2005) 138-145
9. Behets G.J., Dams G., Vercauteren S., Damment S.J., Bouillon R., De Broe M., et al. Does the phosphate binder lanthanum carbonate affect bone in chronic renal failure rats?. J. Am. Soc. Nephrol. 15 (2004) 2219-2228
10. Cummings S.R., Browner W.S., Bauer D., Stone K., Ensrud K., Jamal S., et al. Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. N. Engl. J. Med. 339 (1998) 733-738
11. Behets G.J., Gritters M., Dams G., De Broe M.E., and D'Haese P.C. Effects of efficient phosphate binding on bone in chronic renal failure rats. Renal Failure 27 (2005) 475-484
12. Ott S.M., Maloney N.A., Coburn J.W., Alfrey A.C., and Sherrard D.J. The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. N. Engl. J. Med. 307 (1982) 709-713
13. Parfitt A.M. Bone histomorphometry: proposed system for standardization of nomenclature, symbols, and units. Calcif. Tissue Int. 42 (1988) 284-286
14. White M.A. A comparison of inductively coupled plasma mass spectrometry with electrothermal atomic absorption spectrophotometry for the determination of trace elements in blood and urine from non occupationally exposed populations. J. Trace Elem. Med. Biol. 13 (1999) 93-101
15. D'Haese P.C., Couttenye M.M., Lamberts L.V., Elseviers M.M., Goodman W.G., Schrooten I., et al. Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients. Clin. Chem. 45 (1999) 1548-1556
16. IFCC Scientific Committee, Rinker A.D., and Shaw L.M. IFCC methods for the measurement of catalytic concentration of enzymes. Part 5. IFCC method alkaline phosphatase. J. Clin. Chem. Clin. Biochem. 21 (1983) 731-748
17. Lieuallen W.G., Weisbrode S.E., Horst R.L., and Nagode L.A. The effects of uremia and dietary phosphorus on the bone of rats. Bone 11 (1990) 41-46
18. Lotz M., Zisman E., and Bartter F.C. Evidence for a phosphorus-depletion syndrome in man. N. Engl. J. Med. 278 (1968) 409-415
19. Everett R.M. Collection and use of clinical and hematological reference ranges for laboratory animals. Clin. Chem. 30 (1984) 1079
20. Frajewicki V., Kohan R., Abu-Ata M., Leiba M., Cohen O., and Ben Ari J. Intraperitoneal phosphate administration in hungry bone syndrome. Clin. Nephrol. 34 (1990) 223-224
21. Behets G.J., Verberckmoes S.C., Oste L., Bervoets A.R., Cox C., Denton J., et al. Localisation of lanthanum in bone of chronic renal failure rats after oral dosing with lanthanum carbonate. Kidney Int. 67 (2005) 1830-1836
22. Goodman W.G. Bone disease and aluminum: pathogenic considerations. Am. J. Kidney Dis. 6 (1985) 330-335
23. Andress D.L., Maloney N.A., Endres D.B., and Sherrard D.J. Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population. J. Bone Miner. Res. 1 (1986) 391-398
24. Sedman A.B., Alfrey A.C., Miller N.L., and Goodman W.G. Tissue and cellular basis for impaired bone formation in aluminum-related osteomalacia in the pig. J. Clin. Invest. 79 (1987) 86-92
25. Dunstan C.R., Evans R.A., Hills E., Wong S.Y., and Alfrey A.C. Effect of aluminum and parathyroid hormone on osteoblasts and bone mineralization in chronic renal failure. Calcif. Tissue Int. 36 (1984) 133-138